Skip to main content
. 2024 Jul 1;10(13):e33684. doi: 10.1016/j.heliyon.2024.e33684

Table 2.

Types and grades of immune-related adverse events described in our cohort.

No. (%) GRADE (%)
1 2 3 4
Infusion reaction 1 (1.8) 100.0
Endocrine 5 (9.1) 40.0 60.0
Pneumonitis 6 (10.9) 16.7 66.7 16.7
Colitis 2 (3.6) 100.0
Hepatitis 3 (5.5) 33.3 33.3 33.3
Nephritis 4 (7.3) 25.0 25.0 50.0
Neurologic 1 (1.8) 100.0
Musculoskeletal 5 (9.1) 40.0 20.0 40.0
Skin 6 (10.9) 50.0 33.3 16.7
Cardiovascular 1 (1.8) 100.0
Ocular 1 (1.8) 100.0
Other 1 (1.8) 100.0